Marcain Polyamp Steripack

Bupivacaine hydrochloride, the active ingredient in Marcain Polyamp Steripack, is a local anesthetic (amide) presented as a sterile solution for epidural and infiltration use. It provides prolonged regional anesthesia for surgical and obstetric procedures, reducing pain transmission in the targeted area, and is commonly employed in adult patients undergoing various types of surgery.

GNH USA supplies Marcain Polyamp Steripack as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide, ensuring quality compliance with EU standards and reliable global distribution.

Bupivacaine hydrochloride is a long‑acting amide local anesthetic used to block nerve conduction in regional anesthesia.

- Epidural anesthesia: Provides prolonged sensory block for labor, delivery, or postoperative pain control. - Infiltration anesthesia: Produces localized numbness for minor surgical or dental procedures. - Peripheral nerve block: Offers targeted anesthesia for limb surgeries.

Adverse reactions may occur following administration of bupivacaine hydrochloride.

Common Side Effects: - Injection site pain or irritation - Transient hypotension - Bradycardia - Nausea or vomiting - Dizziness or light‑headedness - Metallic taste in the mouth

Serious or Rare Side Effects: - Cardiac arrhythmias or cardiac arrest - Seizures - Respiratory depression or apnea - Severe allergic reaction (anaphylaxis) - Prolonged motor block - Methemoglobinemia (rare)

When using Marcain Polyamp Steripack, clinicians should observe the following precautions.

- Allergy assessment: Verify no known hypersensitivity to amide‑type local anesthetics. - Dose minimisation: Use the lowest effective dose to achieve the desired block. - Cardiovascular monitoring: Observe heart rate and blood pressure during and after injection. - Avoid intravascular injection: Aspirate before administration to prevent systemic toxicity. - Hepatic impairment: Adjust dosing in patients with significant liver disease. - Pregnancy considerations: Use only if the anticipated benefit outweighs potential risk to the fetus. - Store at room temperature: Keep in the original packaging, protect from light and moisture.

Bupivacaine hydrochloride may interact with other medicines, requiring attention to potential additive effects.

Major Interactions (Avoid): - Concurrent use of other local anesthetics: Increases risk of cumulative systemic toxicity. - Class I antiarrhythmic agents (e.g., quinidine, procainamide): Heighten cardiotoxic potential. - Beta‑blockers: May exacerbate bradycardia and hypotension.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., erythromycin, ketoconazole): May raise plasma concentrations of bupivacaine. - Diuretics: Can alter plasma protein binding, affecting free drug levels. - General anesthetics (e.g., propofol, volatile agents): May potentiate central nervous system depression.